Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Merola

Showing results (221-230 of 442) with videos related to

Pageof 45
Sort By:
Dermatology and Therapy|July 11, 2023
Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support ProgramAlice B Gottlieb, Russel Burge, William N Malatestinic, et al.
Arthritis Care & Research|August 15, 2017
Patterns of Systemic Treatment for Psoriatic Arthritis in the US: 2004-2015Moa P Lee, Joyce Lii, Yinzhu Jin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 4, 2022
Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature reviewJörg C Prinz, Siew Eng Choon, Christopher E M Griffiths, et al.
The Journal of Rheumatology|April 3, 2015
Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical TestingDeepak A Rao, Kevin Wei, Joseph F Merola, et al.
The Journal of Rheumatology|April 16, 2022
Potential Impact of Sex and BMI on Response to Therapy in Psoriatic Arthritis: Post Hoc Analysis of Results From the SEAM-PsA TrialPhilip J Mease, Dafna D Gladman, Joseph F Merola, et al.
Journal of Drugs in Dermatology : JDD|December 5, 2023
Successful Treatment of Keloids and Hypertrophic Scars With Systemic and Intralesional DupilumabMichelle S Min, Daniel R Mazori, Michelle S Lee, et al.
American Journal of Clinical Dermatology|August 28, 2019
Treatment of Medicare Patients with Moderate-to-Severe Psoriasis who Cannot Afford Biologics or ApremilastNicola E Natsis, Joseph F Merola, Jeffrey M Weinberg, et al.
JAMA Dermatology|April 28, 2016
Tofacitinib Citrate for Refractory Cutaneous Dermatomyositis: An Alternative TreatmentDrew J B Kurtzman, Natalie A Wright, Janice Lin, et al.
The British Journal of Dermatology|November 26, 2013
Diagnosing and treating psoriatic arthritis: an updateW H Boehncke, A Qureshi, J F Merola, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2020
Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate-to-severe genital psoriasisJ F Merola, P-D Ghislain, J N Dauendorffer, et al.
Pageof 45

Showing results (221-230 of 442) with videos related to

Sort By:
Pageof 45
Dermatology and Therapy|July 11, 2023
Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support ProgramAlice B Gottlieb, Russel Burge, William N Malatestinic, et al.
Arthritis Care & Research|August 15, 2017
Patterns of Systemic Treatment for Psoriatic Arthritis in the US: 2004-2015Moa P Lee, Joyce Lii, Yinzhu Jin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 4, 2022
Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature reviewJörg C Prinz, Siew Eng Choon, Christopher E M Griffiths, et al.
The Journal of Rheumatology|April 3, 2015
Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical TestingDeepak A Rao, Kevin Wei, Joseph F Merola, et al.
The Journal of Rheumatology|April 16, 2022
Potential Impact of Sex and BMI on Response to Therapy in Psoriatic Arthritis: Post Hoc Analysis of Results From the SEAM-PsA TrialPhilip J Mease, Dafna D Gladman, Joseph F Merola, et al.
Journal of Drugs in Dermatology : JDD|December 5, 2023
Successful Treatment of Keloids and Hypertrophic Scars With Systemic and Intralesional DupilumabMichelle S Min, Daniel R Mazori, Michelle S Lee, et al.
American Journal of Clinical Dermatology|August 28, 2019
Treatment of Medicare Patients with Moderate-to-Severe Psoriasis who Cannot Afford Biologics or ApremilastNicola E Natsis, Joseph F Merola, Jeffrey M Weinberg, et al.
JAMA Dermatology|April 28, 2016
Tofacitinib Citrate for Refractory Cutaneous Dermatomyositis: An Alternative TreatmentDrew J B Kurtzman, Natalie A Wright, Janice Lin, et al.
The British Journal of Dermatology|November 26, 2013
Diagnosing and treating psoriatic arthritis: an updateW H Boehncke, A Qureshi, J F Merola, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2020
Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate-to-severe genital psoriasisJ F Merola, P-D Ghislain, J N Dauendorffer, et al.
Pageof 45